Indiana to cover part of GLP-1 costs for Medicaid recipients

2 min read

Indiana announced it will join the federal BALANCE demonstration to reduce obesity among Medicaid recipients by negotiating GLP-1 drug pricing with manufacturers. Under the agreement described in a governor's news release, manufacturers would provide GLP-1s at $245 per person per month, with Indiana paying $85 and the federal government covering the remainder for eligible Medicaid members living with obesity. The announcement noted praise from leaders at Eli Lilly and Novo Nordisk and cited a CDC survey reporting 38% adult obesity in Indiana. More details on eligibility and an implementation timeline are pending.

Indiana will pay $85 monthly per Medicaid member for GLP-1s.